Susan Krashinsky Robertson

Kate Helmore, Globe and Mail reporter on agriculture and food manufacturing, and Susan Krashinsky Robertson, Globe retailing reporter expert on grocers and shelf strategy, discuss Canadian origin labels, the 98% rule and gray zones in labeling. They talk about the surge in origin complaints, how retailers handle shelf space and promotion, and the debate over fines versus encouraging Canadian products.

In this discussion, retailing reporter Susan Krashinsky Robertson unpacks the failed bid of B.C. billionaire Ruby Liu to acquire former Hudson’s Bay leases. Liu, known for her real estate prowess but lacking major retail experience, envisioned revitalizing the Bay. The conversation reveals intense landlord skepticism, courtroom drama, and Liu's controversial practices, including discrepancies in hiring commitments. The implications of this case on future lease assignments also emerge, leaving listeners curious about Liu’s next moves.

In this discussion, Susan Krashinsky Robertson, a retail journalist for The Globe and Mail, delves into the Hudson's Bay Company's founding charter from 1670. This unique document has sparked a multimillion-dollar debate over ownership and historical significance. Susan explores the challenges of selling such a pivotal artifact amid creditor pressures and highlights the bids from Canada's wealthiest families. Key issues arise around cultural implications, Indigenous rights, and who truly gets to own a piece of history.

Susan Krashinsky Robertson, a retail business reporter from The Globe, dives into the shocking allegations against Popeyes Chicken. She discusses a lawsuit claiming franchisees bought ‘unsafe’ meat from unauthorized sources. The conversation reveals corporate surveillance efforts to investigate quality control issues and questionable delivery practices. Robertson elaborates on the implications of such disputes for food safety and the brand's reputation, highlighting the complexities of maintaining standards in fast food franchising.

Susan Krashinsky Robertson, a Globe business reporter, shares her insights on Librela, the controversial arthritis drug for dogs. Some pet owners celebrate its effects, claiming happier, more comfortable pets. However, troubling cases of adverse reactions, including severe lethargy and even death, raise serious concerns. Krashinsky discusses her interviews with pet owners and veterinarians, revealing a critical divide about the drug's safety and the need for better communication in veterinary care. The growing popularity of Librela prompts a closer examination of its risks and regulatory practices.